Sodium Bicarbonate
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Exela Pharma Sciences, LLC | unknown | 7 | SUPPLYING |
| Hospira, Inc. | brand | 5 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 5 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 5 | SUPPLYING |
| Anthea Pharma Private Limited | unknown | 2 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| Civica, Inc | unknown | 2 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 2 | SUPPLYING |
| Omnivium Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | repackager | 2 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 2 | SUPPLYING |
| Amneal Pharmaceuticals Private Limited | unknown | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 1 | SUPPLYING |
| Steriscience Specialties Private Limited | unknown | 1 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 1 | SUPPLYING |
+ 4 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Lack of Assurance of Sterility. — Recalling firm: PFIZER INC — U.S. Nationwide
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested. — Recalling firm: Exela Pharma Sciences LLC — Nationwide in the USA
Lack of Assurance of Sterility — Recalling firm: Exela Pharma Sciences LLC — Nationwide
Presence of Particulate Matter; identified as glass — Recalling firm: Pfizer Inc. — Nationwide in the USA and Puerto Rico.
Presence of Particulate Matter: Silicone — Recalling firm: Exela Pharma Sciences LLC — Nationwide
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration. — Recalling firm: Exela Pharma Sciences LLC — Nationwide within the United States
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration — Recalling firm: Exela Pharma Sciences LLC — Nationwide within the United States
Sodium Bicarbonate Injection — reported in shortage by Exela Pharma Sciences, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
Sodium Bicarbonate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
Sodium Bicarbonate Injection — reported in shortage by Long Grove Pharmaceuticals LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
Sodium Bicarbonate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric.
